Drug recall
Red Blood Cells (Apheresis)
FDA recall event 52254 · Class II · New York Blood Center, Inc.
Key facts
| Event ID | 52254 |
|---|---|
| Recall numbers | B-0865-13, B-0866-13 |
| Recalling firm | New York Blood Center, Inc. |
| Product type | Biologics |
| Products | Red Blood Cells (Apheresis), Red Blood Cells (Apheresis) Irradiated |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Blood products, which did not meet the acceptable product specifications, were distributed. |
| Initiation date | Mar 9, 2009 |
| Report date | Feb 6, 2013 |
| Termination date | Jan 29, 2013 |
| City | New York |
| State | NY |
| Country | United States |
| FEI number | 2476837 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: